Invented by Omar F. Khan, Jasdave S. Chahal, Daniel G. Anderson, Hidde Ploegh, Robert S. Langer, Tyler E. Jacks, David A. Canner, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology

The market for compositions and methods for modified dendrimer nanoparticle delivery is experiencing significant growth and is poised to revolutionize various industries, including healthcare, electronics, and environmental science. Dendrimers, highly branched and symmetric macromolecules, have gained immense attention due to their unique properties and potential applications in drug delivery, gene therapy, imaging, and sensing. Dendrimer nanoparticles offer several advantages over traditional drug delivery systems. Their well-defined structure allows for precise control over size, shape, and surface functionality, enabling targeted delivery to specific cells or tissues. Additionally, dendrimers can encapsulate a wide range of therapeutic agents, including small molecules, proteins, nucleic acids, and imaging agents, enhancing their stability and bioavailability. One of the key drivers of the market for modified dendrimer nanoparticle delivery is the increasing demand for personalized medicine. Dendrimers can be tailored to carry specific drugs or therapeutic agents, allowing for individualized treatment strategies. This personalized approach has the potential to improve patient outcomes and reduce adverse effects. In the healthcare sector, dendrimer-based drug delivery systems are being explored for various applications. For instance, in cancer therapy, dendrimers can selectively accumulate in tumor tissues, delivering chemotherapeutic drugs directly to cancer cells while minimizing damage to healthy tissues. This targeted approach enhances the efficacy of treatment and reduces systemic toxicity. Furthermore, dendrimer nanoparticles are being investigated for their potential in gene therapy. By encapsulating nucleic acids, such as DNA or RNA, dendrimers can protect them from degradation and facilitate their delivery into cells. This opens up possibilities for treating genetic disorders, as well as developing vaccines and gene editing technologies. The electronics industry is also recognizing the potential of dendrimer nanoparticles. Their unique properties, such as high solubility, low viscosity, and good film-forming ability, make them ideal candidates for various electronic applications. Dendrimers can be used as conductive materials, dielectric layers, or as components in organic light-emitting diodes (OLEDs). Their precise control over size and shape also enables the fabrication of nanoscale electronic devices. In the field of environmental science, dendrimer nanoparticles are being explored for their ability to remove pollutants from water and air. Their large surface area and functional groups allow for efficient adsorption and catalytic degradation of contaminants. Dendrimer-based materials can also be used for the detection and sensing of environmental pollutants, enabling real-time monitoring and remediation. As the market for compositions and methods for modified dendrimer nanoparticle delivery continues to grow, several challenges need to be addressed. These include the optimization of dendrimer synthesis methods, enhancing their stability and biocompatibility, and scaling up production to meet the increasing demand. Additionally, regulatory considerations and safety assessments are crucial to ensure the safe and effective use of dendrimer-based products. In conclusion, the market for compositions and methods for modified dendrimer nanoparticle delivery is witnessing rapid growth and holds immense potential across various industries. The unique properties of dendrimer nanoparticles, coupled with their precise control over size and surface functionality, make them attractive candidates for targeted drug delivery, gene therapy, electronics, and environmental applications. Continued research and development efforts, along with regulatory support, will drive the commercialization of dendrimer-based products and pave the way for innovative solutions in healthcare, electronics, and environmental science.

The Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology invention works as follows

Compositions for modified dendrimer (?MDNP?) nanoparticles” The delivery of therapeutic, diagnostic and/or prophylactic agents such as large RepRNA molecules into the cells of an individual has been developed. MDNPs drive the proliferation of intracellular antigen-specific cells and enhance antigen-specific antibodies. MDNPs are capable of multiplexing to deliver different repRNAs in order to alter the expression kinetics for encoded antigens, and simultaneously deliver repRNAs as well as mRNAs that contain the same UTR element to promote expression of encoded Antigens.

Background for Compositions and methods for modified dendrimer nanoparticle delivery

I. Definitions

II. Compositions for the Delivery of Proteins Small Molecules Nucleic Acids into Cells

1. Ionizable Dendrimer-Based Nanomaterial

a. Epoxides

2. “2.

a. Hydrophobic component

b. Hydrophilic component

3. “3.

a. Nucleic Acids

b. Antigens

c. Other therapeutic or prophylactic agents

4. Multiplexed Modified Dendrimer-Based Nanoparticles

1. “1.

2. “2.

III. Methods for Making Modified Dendrimer-Based Nanoparticles

IV. “IV.

1. Vaccination Strategies for Multiple repRNAs

2. “2.

a. Cancer

b. “Infectious Diseases

c. Allergies

Click here to view the patent on Google Patents.